News

Fierce Biotech3d
AstraZeneca culls a Lilly-partnered Alzheimer's drug alongside 2 other neuroscience meds in Q1 clear-out
AstraZeneca has axed three MedImmune legacy monoclonal antibody drugs from its neuroscience pipeline in a first-quarter clear ...
2025 AACR Innovent Presents Preclinical Data Of Multiple Novel Molecules Including Bispecific And Tri-Specific Antibodies And Bispecific Adcs
SAN FRANCISCO and SUZHOU, China, April 27, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutic ...
The Victoria Advocate5d
2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs
Preclinical studies demonstrate superior anti-tumor efficacy compared to PD1 mAb alone in multiple mouse ... global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab, LG Chem ...
Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds
Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio.
Seeking Alpha4d
Eli Lilly: Why Orforglipron Matters, A Lot
The last couple of quarters have been very favorable for Eli Lilly and ... to manufacture this product at scale to compete with orforglipron. On the other hand, Eli Lilly expects orforglipron ...
Yahoo Finance3d
What To Expect From Eli Lilly’s (LLY) Q1 Earnings
Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow before market hours. Here’s what to look for. Eli Lilly met analysts’ revenue expectations last quarter ...